期刊
CURRENT OPINION IN PHYSIOLOGY
卷 2, 期 -, 页码 42-50出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.cophys.2017.12.007
关键词
-
类别
资金
- NICHD NIH HHS [U54 HD083091] Funding Source: Medline
- NINDS NIH HHS [R01 NS025704] Funding Source: Medline
Dravet syndrome is a devastating childhood epilepsy disorder with high incidence of premature death plus co-morbidities of ataxia, circadian rhythm disorder, impaired sleep quality, autistic-like social-interaction deficits and severe cognitive impairment. It is primarily caused by heterozygous loss-of-function mutations in the SCN1A gene that encodes brain voltage-gated sodium channel type-1, termed Na(V)1.1. Here I review experiments on mouse genetic models that implicate specific loss of sodium currents and action potential firing in GABAergic inhibitory interneurons as the fundamental cause of Dravet syndrome. The resulting imbalance of excitatory to inhibitory neurotransmission in neural circuits causes both epilepsy and co-morbidities. Promising therapeutic approaches involving atypical sodium channel blockers, novel drug combinations, and cannabidiol give hope for improved outcomes for Dravet syndrome patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据